• Dorsomorphin (Compound C): Reliable AMPK/BMP Inhibition in C

  2026-05-09

  This article offers an evidence-driven, scenario-based guide to deploying Dorsomorphin (Compound C) (SKU B3252) for precise AMPK pathway inhibition and BMP4/Smad signaling studies. We address common laboratory challenges—ranging from protocol reproducibility to vendor reliability—supporting biomedical researchers with best practices grounded in recent literature and product specifications.

• Hyperthermia Sensitizes BRCA2-Proficient Ovarian Cancer to P

  2026-05-08

  Mei et al. (2025) reveal that hyperthermia-induced reduction of BRCA2 protein can sensitize BRCA2-proficient ovarian carcinoma cells to PARP inhibitor treatment. This discovery provides a mechanistically supported strategy for overcoming intrinsic PARPi resistance in a substantial subset of ovarian cancers, with direct implications for combination therapy design.

• Cyclophilin A Loss Confers Cyclosporine Resistance in Mice

  2026-05-08

  This study establishes that cyclophilin A (CypA) is essential for cyclosporine-mediated immunosuppression in mice. By demonstrating that CypA-deficient immune cells and animals are resistant to cyclosporine but not necessarily to other calcineurin inhibitors, this work clarifies the molecular specificity underlying immunosuppressive drug action and informs the selection of research tools in transplantation and autoimmune disease models.

• AGO1 Regulates Stemness via Protein Folding in mESC Fate Dec

  2026-05-07

  This study uncovers an RNA-independent function for AGO1 in mouse embryonic stem cells (mESCs), showing that it maintains pluripotency by facilitating protein folding through HOP interaction. The findings distinguish AGO1’s mechanism from AGO2 and highlight novel regulatory layers in stem cell fate control, informing improved strategies for pluripotency maintenance and differentiation.

• Selective Spectrophotometric Quantification of Phenolic β-La

  2026-05-07

  This article examines the development and validation of two selective spectrophotometric methods for the quantitative analysis of phenolic β-lactam antibiotics, including amoxicillin, cefoperazone, cefadroxil, and cefprozil. The innovation lies in rapid, cost-effective assays suitable for routine quality control and research, even in the presence of structurally related penicillins such as dicloxacillin.

• G418 Sulfate (Geneticin): Precision Selection and Antiviral

  2026-05-06

  G418 Sulfate (Geneticin) is more than a classic selection antibiotic—its dual action as a rigorous genetic engineering tool and an emerging antiviral agent sets it apart in modern research. This article unpacks workflow best practices, advanced applications, and troubleshooting strategies to maximize reliability and experimental success with APExBIO's ultra-pure Geneticin, G-418 Sulfate.

• Salinomycin: Polyether Ionophore Antibiotic for HCC Research

  2026-05-06

  Salinomycin, a polyether ionophore antibiotic, uniquely targets hepatocellular carcinoma via disruption of ABC drug transporters and the Wnt/β-catenin pathway. This article delivers actionable, data-driven workflows for maximizing assay reproducibility and overcoming common experimental challenges in cancer cell apoptosis research.

• Intra- and Extracellular Dicloxacillin Activity Against MSSA

  2026-05-05

  This study rigorously compares the intra- and extracellular antimicrobial efficacy of dicloxacillin against MSSA using both in vitro human macrophage and in vivo mouse peritonitis models. By integrating pharmacokinetic-pharmacodynamic (PK/PD) analysis, the paper identifies key determinants of antibiotic response, supporting more precise experimental and therapeutic approaches.

• Taraxasterol Suppresses Necroptosis to Counter Osteoporosis

  2026-05-05

  This study demonstrates that taraxasterol alleviates osteoporosis by modulating the PI3K/AKT/PPARγ axis, suppressing necroptosis, and reversing osteogenic–adipogenic imbalance in bone marrow mesenchymal stem cells (BMSCs). The findings offer new mechanistic insights into bone-fat homeostasis and highlight necroptosis as a viable therapeutic target in osteoporosis research.

• WNT5a/GSK3/β-catenin Axis Controls FAP Adipogenesis in Muscl

  2026-05-04

  This study elucidates how the WNT5a/GSK3/β-catenin signaling axis regulates adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors (FAPs). The findings reveal key regulatory mechanisms underlying muscle fatty degeneration and suggest new strategies for targeting intramuscular fat accumulation in myopathies.

• Decoding 5-hmC: Strategic Leverage of 5-hme-dCTP in Plant Ep

  2026-05-04

  This thought-leadership article explores the transformative potential of 5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) as a tool for high-resolution epigenetic mapping, with a focus on its role in dissecting the context-dependent dynamics of 5-hydroxymethylcytosine (5hmC) during plant drought response. We bridge mechanistic insight with actionable strategy for translational researchers, contextualizing recent landmark findings in rice and offering best-practice protocol guidance, competitive analysis, and a forward-looking synthesis on crop resilience engineering. The discussion escalates beyond standard product listings, integrating APExBIO’s solution into a broader vision for next-generation epigenomic discovery.

• ICG001 (SKU A8217): Reliable Wnt/β-Catenin Pathway Inhibitio

  2026-05-03

  This article addresses real laboratory challenges in cell-based assays, focusing on how ICG001 (SKU A8217) enables reproducible Wnt/β-catenin pathway inhibition for cancer and fibrosis models. Drawing on literature and practical experience, it guides researchers in protocol optimization, data interpretation, and vendor selection for ICG001.

• EZ Cap™ Human PTEN mRNA (ψUTP): Applied Protocols & Cancer R

  2026-05-02

  EZ Cap™ Human PTEN mRNA (ψUTP) offers robust PTEN re-expression for translational cancer research, with unmatched mRNA stability and immune evasion. Explore detailed, data-driven workflows and troubleshooting insights for high-fidelity PI3K/Akt pathway inhibition and drug resistance reversal in mammalian systems.

• Tolazoline as an α2-Adrenergic Receptor Antagonist: Applied

  2026-05-01

  Tolazoline empowers researchers to modulate α2-adrenergic signaling and potassium channel function, driving robust in vitro and animal model assays for insulin secretion and airway smooth muscle studies. This guide translates Tolazoline’s pharmacology into actionable protocols, troubleshooting insights, and strategic assay enhancements.

• Cefotaxime in Antimicrobial Resistance Research: Protocols &

  2026-05-01

  Cefotaxime, a third-generation cephalosporin antibiotic, empowers scientists to dissect antimicrobial resistance mechanisms and construct robust bacterial infection models. This guide delivers actionable workflows, troubleshooting strategies, and real-world insights—grounded in the latest multidrug resistance epidemiology and supported by APExBIO’s quality standards.

15666 records 1/1045 page Next 12345 下5页 Last page